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\s=b\First-degree relatives of patients with
Alzheimer's disease (AD) are at greater
risk for dementia when compared with the
relatives of their healthy peers, but not
when compared with the relatives of pa-
tients with Parkinson's disease. This may
indicate that the risk of dementia in these
relatives is not specific to AD or that these
studies are biased. We obtained a family
history and vital status information on
each first-degree relative of patients at-
tending a clinic and in a group of recruited
healthy elderly subjects. Patients formed
two groups: probable AD and other forms
of dementia or cognitive disorders without
dementia. The odds of dementia in first\x=req-\
degree relatives did not differ between
patient groups. The odds of dementia in
relatives of patients with probable AD or
other forms of dementia was six times that
in the relatives of the healthy elderly sub-
jects. The cumulative incidence of demen-
tia increased with age in the first-degree
relatives of all subjects. Approximately
50% of the first-degree relatives of pa-
tients with AD were demented by age 91
years, but almost the same number of the
other patient group's relatives were de-
mented as well. That figure was never
reached in the healthy elderly subject's
relatives. Because the risk of dementia in
first-degree relatives of patients with AD
was similar to that for patients with other
disorders, we cannot exclude the possi-
bility that this is the result of selection and
information biases. Our investigation im-
plies that the increased risk of dementia
may not be specific to relatives of patients
with AD; the risk may also be increased in
first-degree relatives of patients with
other neurologic disorders.
(Arch Neurol. 1991;48:269-273)
Qeveral case-control1'6 and cohort
studies79 provide evidence support¬
ing a genetic cause for Alzheimer's
disease (AD). The cumulative inci¬
dence of an Alzheimer-like dementia
in first-degree relatives of patients
with AD may be as high as 50% by the
eighth decade of life.12·811 Although
there is a great deal of consistency in
those investigations, Farrer et al11 did
not find an increased risk of dementia
in first-degree relatives of patients
with AD compared with the first-
degree relatives of patients with Par¬
kinson's disease. This indicates that
either the increased risk of dementia is
not specific to relatives of patients
with AD, or that there could be a bias
in the way these studies are conducted.
We systematically recorded infor¬
mation about first-degree relatives at
the initial visit, before the diagnosis
was established, in every patient at¬
tending an urban clinic for memory
disorders. We estimated the cumula¬
tive incidence of dementia in the first-
degree relatives of patients with clin¬
ically diagnosed AD and other dis¬
orders, including other types of
dementia, and in a group of healthy
elderly control subjects. We wanted to
determine whether the increased risk
of dementia in first-degree relatives of
patients with AD is on a genetic basis,
and whether this is specific to AD or
whether it is due to a selection bias be-
cause of heightened awareness in the




Patients.—Data from 222 consecutive per¬
sons attending a state-supported clinic for
memory disorders during a 2-year period in
the Washington Heights-Inwood neighbor¬
hood of northern Manhattan and the bor¬
dering area were used in this study. Pa¬
tients were referred to the clinic by private
physicians in the surrounding area, and
about half were self-referred.
Before coming to the clinic, patients were
screened in a semi-structured telephone in¬
terview with the responsible family mem¬
ber. The purpose of this interview was to
exclude people younger than 30 years, or
those with a lifetime history of epilepsy or
primary psychiatric disorder, such as
schizophrenia. Patients with Huntington's
disease, stroke, and other major neurologic
diseases were also excluded by the tele¬
phone interview, where possible, and re¬
ferred to other clinics.
Healthy Elderly Comparison Group.—
Elderly adult volunteers were also re¬
cruited from the community. A letter was
written asking the recipient to participate
in a study on aging and memory. We also
asked elderly relatives of patients with
cerebrovascular disorders in the Presbyte¬
rian Hospital, New York, NY, and members
of local senior centers to participate. No
details about the study hypotheses were
provided until after the subjects completed
their participation in the study.
Clinical Assessment
Information regarding medical health,
all medications used during the last year,
history of their present illness, and both
present and past psychiatric records were
filed in a standardized recording format.
All subjects were rated on their ability to be
independent in daily activities.
All patients and healthy elderly control
subjects received a physical and neurologic
examination. Most patients, and all control
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subjects, received a neuropsychologic test
battery. Patients with dementia were hos¬
pitalized to undergo a computed tomo¬
graphic scan of the head, lumbar puncture,
electroencephalogram, blood test, and neu¬
ropsychologic tests unless these procedures
had been performed within the last year
and were available for review.
A diagnosis for every patient and re¬
cruited subject was made after all clinical
studies were completed. Each chart was
then independently reviewed by two of us(R.M. and Y.S.) to render a diagnosis. The
family history was not used in the diagnos¬
tic process at any level. Criteria for primary
degenerative dementia were those from the
Diagnostic and Statistical Manual of Men¬
tal Disorders-III-Revised,'2 and criteria for
Alzheimer's disease were those suggested
by the National Institute of Neurological
Disorders and Stroke-Alzheimer's Disease
and Related Disorders Association Work
Group.13
Family History
A semistructured family history ques¬
tionnaire, similar to published versions14
was used in all subjects, patients, and the
responsible family members or compan¬
ions, who acted as informants. The pedigree
for all known first-degree relatives was re¬
corded and reviewed at the time of data
collection with the responsible informant(attendants or nursing aides were not con¬
sidered as informants).
The semistructured format for the fam¬
ily history began with standardized ques¬
tions about each first-degree relative (par¬
ents and siblings only; children of probands
were excluded) to determine age, sex, posi¬
tion in the family, and the presence of
"Alzheimer's disease, dementia, senility, or
memory loss." Additional nonstandardized
questions were used when needed to clarify
the presence and type of dementia. The in¬
terview was directed to both the patient and
the family member (or family members if
there was more than one); disagreements
between them were resolved before record¬
ing the response. The age at death and the
cause of death were recorded, as was the
current age if still alive when available.
When a family reported dementia, follow-
up questions were asked to determine
whether the affected relative was still alive
or now dead.
Breitner and Margruder-Habib'5 recom¬
mended using a standard time after pre¬
sumed onset to establish "caseness" and
"onset," but we did not believe that the in¬
formants or the patients could reliably es¬
timate the date of onset of symptoms in
relatives as well as in the proband. There¬
fore, for all groups we consistently used the
current age, if alive, or the age at death re¬
ported by the proband's informant to esti¬
mate age cumulative incidence in first-de¬
gree relatives and avoid an inaccurate esti¬
mate of date of "onset." This approach was
nondifferential to any group of subjects.
The interviewer recording the pedigree was
blinded to the final clinical diagnosis of the
proband. Records were not used if they were
incomplete or if there was some question







Major depression with dementia 3
Head injury 3
Brain tumor 2
Focal effects of stroke 2
Progressive supranuclear palsy 1
Multiple sclerosis 1
Creutzfeldt-Jakob disease 1
Giant cell arteritis 1
Unknown 3
*N = 25.
Database Management and Analysis
All information was entered and stored
in a database (CLINFO system). Analysis
of variance and statistical methods for
rates and proportions were used to compare
characteristics of the three groups." The
SAS logistic regression was used to adjust
relative-risk estimates, and the SAS prod¬
uct-limit survival estimates were used to
estimate the cumulative incidence of de¬
mentia in the first-degree relatives." Power




Two hundred twenty-two patients
were evaluated in the Memory Disor¬
ders Clinic (New York, NY) during the
2-year study period. One hundred four¬
teen patients met the criteria for prob¬
able AD,13 but only 110 patients had
adequate information to provide a ped¬
igree of first-degree relatives. These
110 subjects became the AD patient
group.
In the remaining 80 patients, 25 had
other forms of dementia as listed in
Table 1. In the other 55 patients, other
neurologic problems without demen¬
tia, based on neuropsychologic testing
available, were found in all but 15 pa¬
tients, as noted in Table 2. Only 68 of
these 80 patients had adequate infor¬
mation regarding family pedigree of
first-degree relatives. The other 12
were excluded; six were demented and
six were nondemented patients. The 68
subjects became the patient compari¬
son group (PCG).
The agreement above chance on the
diagnosis of dementia for all subjects
and patients by the two clinicians was
substantial (for AD,  = .73 and for
cognitive disorder and all other pa¬
tients,  = .68).16 Any disagreement on
diagnosis was resolved by two of us(R.M. and Y.S.) and a diagnosis was
assigned prior to data analysis. Twen¬
ty-eight patients had AD with an as¬
sociated condition that could have re¬
sulted in dementia and were classified
with possible AD.13 We excluded these
patients to be certain about the clinical
Table 2.—Other Disorders*
Disorders No.
Patients with symptoms but
with no specific disorder





Amnesia of unknown cause
Cognitive impairment
dementia with head injury
Unclassified psychiatric
disorder




diagnosis of AD and to avoid AD in the
PCG. Since the development of these
cohorts the diagnoses in the AD and
PCG have not changed over 2 years.
Thus, we were confident in our clinical
diagnoses of AD and other dementias.
We excluded 68 of the 140 recruited
healthy elderly control subjects be¬
cause the neurologic and neuropsycho¬
logic examination indicated some form
of intellectual impairment, and 13 oth¬
ers were excluded because of inade¬
quate family history. The remaining
59 healthy elderly subjects formed the
healthy elderly group (HEG).
Demographics
The patients with probable AD and
the HEG were similar in age, and both
were significantly older than the PCG.
The AD and the PCG differed in edu¬
cation, but there was no difference in
education between the patients with
AD and the HEG. The probable AD
and HEG cohorts had a similar mean
number of first-degree relatives per
family, but the PCG had fewer first-
degree relatives than the healthy eld¬
erly subjects. Each of these results are
presented in Table 3.
Dementia in First-Degree Relatives
The relatives of patients with prob¬
able AD group were significantly older,
which resulted in a greater number of
lifetime years at risk than the rela¬
tives of either the PCG or the HEG.
The number of demented first-degree
relatives was significantly higher for
the patients with probable AD; there
was no difference between the other
two groups as is indicated in Table 4.
The estimated odds ratio was com¬
pared between groups using logistic
regression to adjust for the difference
between groups in mean age for first-
degree relatives (Table 5). The ad¬justed odds associated with dementia
in first-degree relatives of the patients
with probable AD was six times that of
the first-degree relatives of the HEG,
Downloaded From: http://archneur.jamanetwork.com/pdfaccess.ashx?url=/data/journals/neur/16259/ by a Columbia University User  on 06/13/2017
but only 1.6 times that of the relatives
of the PCG. Because the confidence in¬
terval included 1, the odds ratio was
not significantly different for the com¬
parison between relatives of patients
with probable AD and PCG. When the
PCG was divided into those with and
without dementia, the adjusted odds
ratio associated with dementia in the
first-degree relatives of the patients
with probable AD was still no differ¬
ent than that calculated for the rela¬
tives of either portion of the PCG (de¬
mented and nondemented).
Because there was no difference be¬
tween these two groups of first-degree
relatives (AD and PCG), we evaluated
the possibility of a type II error. As¬
suming the log odds ratio for this
comparison was the same as that seen
in AD vs HEG analysis (log odds
ratio = 1.8, SE = 0.3) and an a level of
.05, we calculated the power of the test
to be 99%. Thus, the likelihood of a
type II error in accepting no difference
in odds ratios between first-degree rel¬
atives of patients with AD and those of
the PCG was less than 1%.17
The adjusted odds ratios were also
calculated for the demented and non¬
demented subjects in the PCG and
compared with the HEG as noted in
Table 5. The odds of dementia in the
relatives of the demented PCG was six
times that of the HEG. The odds of de¬
mentia in the relatives of the nonde¬
mented PCG was four times that of the
HEG.
Product-limit survival analysis was
used to estimate the cumulative inci¬
dence of dementia in first-degree rela¬
tives of the three groups. Cumulative
incidence of dementia in the three
groups increased with age as illus¬
trated in the Figure. By age 91 years,
50% of the first-degree relatives of the
probable AD group were considered
demented. However, by the same age
only 20% of the first-degree relatives
of the HEG had developed dementia.
Remarkably, by age 91 years, nearly
40% of the first-degree relatives of the
PCG were considered demented. The
cumulative incidence of dementia in
the first-degree relatives of patients
with AD and the PCG was signifi¬
cantly higher than that in the HEG(log rank test
 2 = 27.48,  < .001). The
cumulative incidence in these two
groups (AD and PCG) did not differ
statistically.
COMMENT
Our data confirm earlier studies110
indicating increased risk of dementia
in the first-degree relatives of patients
with AD when compared with the
first-degree relatives of their healthy
Table 3.—Age, Years of Education, and Number of First-Degree
Relatives in all Subjects*
Subject Group Age, y Education No. of First-Degree Relatives
Probable AD (n = 110) 71.1(10.3) 12.2(4 3) 5.2(2.3)
(range, 48-89)
PCG (n = 68) 65.7(11.6)t 13.9 (4.6) 4.6(2.1)§
(range,34-89)_
HEG ( = 59) 70.4 (6.9) 11.7 (3.9) 5.7 (2.9)
(range, 60-90)
* Probable Alzheimer's disease (AD) represents the patients with clinically diagnosed AD; patient comparison
group (PCG), all of the other patients listed in Tables 1 and 2; healthy elderly group (HEG), recruited healthy
elderly cohort; and numbers within parentheses, mean values with SDs.
tPatient comparison group was younger, F = 6.4, P< .01.
^Patient comparison group had more education, F = 4.4,  < .05.
§Patient comparison group had fewer first-degree relatives, F = 3.6,  < .05.
Table 4.
—
Mean Age of First-Degree Relatives of All Subjects and Percent
Considered Demented*
Subject Group  Current Age or Age at Death, y Demented, %
Probable AD 564 66.3 (13.4)t 9.5*
PCG 298 63.6(15.5) 5.7
HEG 364 63.5 (19.4) 3.4
* Probable Alzheimer's disease (AD) represents the patients with clinically diagnosed AD; patient comparison
group (PCG), all of the other patients listed in Tables 1 and 2; healthy elderly group (HEG), recruited healthy
cohort; N, total number of first-degree relatives; and numbers within parentheses are mean values with SDs.
tRelatives of probable AD group were older, F = 4.36,  < .05.
tPercent of first-degree relatives demented was greater in probable AD group,
 2 = 14.9, P< .001.
Table 5.—Estimated Odds Ratios (Adjusted for Age of the First-Degree Relatives) for
Dementia in First-Degree Relatives of Patients With AD, the Patient Comparison Group,
and the Healthy Elderly Group*
_Subjects_Odds Ratios_95% CI
Probable AD vs combined patient comparison group 1.58 0.88,2.86
Probable AD vs patient comparison group with dementia_0.95_0.42, 2.17
Probable AD vs patient comparison group without dementia_1.96_0.95, 4.85
Probable AD vs healthy elderly group_6.19_2.804, 13.69
Patient comparison group with dementia vs healthy elderly 2.073, 18.10
group_6.12_
Without dementia vs healthy elderly group 3.95 1.38, 11.35
*AD indicates Alzheimer's disease; CI, confidence interval.
peers. However, we have also found
that other neurologic disorders, even
those without dementia, may be asso¬
ciated with almost the same degree of
risk to their first-degree relatives. The
odds for dementia in the first-degree
relatives of patients with AD and the
demented patients in the PCG were
both six times that for relatives for the
HEG after adjusting for age differ¬
ences. Even the relatives of the nonde¬
mented members of the PCG had four
times the risk of the relatives of the
HEG.
There are two major issues to con¬
sider in the interpretation of our re¬
sults: validity, which includes selection
and information bias, and specificity.
Selection Bias
Most case-control studies,1"7 except
for the population-based study of
Hofman et al,9 have identified patients
with AD who voluntarily attend a hos¬
pital or clinic and have then recruited
a healthy individual to represent a
comparison cohort. Patients, or their
family members in the case of AD or
another dementia, may remember
their family history better than the
recruited healthy elderly persons re¬
sulting in what Rocca and Amaducci19
termed an awareness bias. A family
history of dementia would be a strong
motive for seeking medical advice, and
would increase the possibility of iden¬
tifying heredity as a risk factor. Thus,
the increased risk in many of the case-
control studies of AD could be due to
the selection of families with an en¬
hanced knowledge of their family his¬
tory. The relatives of our PCG may
have been influenced by this same bias.
Selection bias may also help to explain







50 60 70 80
Reported Age or Age-at-Death of First-Degree Relatives
100
Analysis showing the cumulative incidence of dementia among first-degree relatives of either pa¬
tients with Alzheimer's disease, subjects from the patient comparison group, or members of the
healthy elderly group. The hatched line indicates relatives of patients with Alzheimer's disease;
dotted line, relatives of the patient control group; straight line, healthy elderly subjects' relatives.
By the age of 91 years, the cumulative incidence of dementia was 48.7% in the relatives of pa¬
tients with Alzheimer's disease, but about 38.9% in the patient comparison groups and less than
23% in the relatives of the healthy control subjects.
why the risk exceeded 50% in some AD
families in another study by Farrer et
al,10 although the risk in excess of 50%
was interpreted as an indication of an
associated environmental factor.
We were unable to obtain family
history data from 15% of the PCG and
18% of the HEG compared with 3.5%
of the AD group, which could lead to an
awareness bias. The inability to obtain
information about some of the first-
degree relatives in two of the groups
could result in a differential misclassi-
fication of cases in these families and
might lead us to reject or favor the
"null hypothesis" of no difference in
risk to first-degree relatives of pa¬
tients with AD.20-21 However, this
would not explain the difference in
risks for relatives between these two
comparison groups. Although differ¬
ential bias may have been present in
the comparison of AD with the HEG,
we believe that our use of a cohort of
patients attending the same clinic less¬
ened the impact of awareness bias
among control subjects.
Information Bias
A second, separate family history
interview was not performed by us, but
we consider the data quality to be as
valid as that collected by others be¬
cause our interview format was
similar.18 As in all previous studies,
and ours, information was obtained in
interviews with other family mem¬
bers. Few "affected" family members
have actually been examined in these
studies. Questionnaires and struc¬
tured interviews can improve reliabil¬
ity of responses, but not the validity. It
is difficult to obtain postmortem data
or even accurate medical records about
dementia in first-degree relatives who
have died. Hofman et al9 obtained and
examined medical records and many of
the secondary cases had had autopsy
confirmation. Those results confirmed,
and to some degree validated, the in¬
creased risk to relatives of patients
with AD in studies where this is not
possible. Farrer et al11 used a weighted
scale to increase accuracy of informa¬
tion regarding probands and first-de¬
gree relatives, but may have underes¬
timated the number of secondary
cases. Without a specific examination
of patients or a tissue diagnosis all
studies are open to information
bias,2021 the magnitude of which de¬
pends on the reliability of the
informants.22 Because we were able to
obtain data concerning risk in first-
degree relatives of patients with AD
similar to that in other studies by our
method, we assume that the data ob¬
tained from the relatives of the HEG
and the PCG were equally valid.
Specificity
Other neurologic disorders can be
familial. Farrer and colleagues11 used
patients with Parkinson's disease as a
comparison group for AD, but found no
difference in risk of dementia in first-
degree relatives of these two groups.
However, because both Hofman et al9
and Marder et al23 have found demen¬
tia and Parkinson's disease to aggre¬
gate in first-degree relatives of pa¬
tients with AD or Parkinson's disease,
this lack of difference in risk might
have been anticipated. Similarly, we
may have introduced this type of prob¬
lem by using patients with other neu¬
rologic disorders as a control group.
The lack of difference in risk of demen¬
tia to first-degree relatives in the study
by Farrer et al11 and our own, could
also indicate that the increased risk of
dementia in first-degree relatives is
not specific to AD and may be present
in a number of neurologic diseases.
We did not attempt to estimate age
at onset of dementia in the relatives
because so few informants could pro¬
vide that information. Farrer et al10
"censored" this type of age estimate,
noting that such estimates increase
the age at onset. Although our ap¬
proach was nondifferential to group,
estimating the correct age at onset
would result in a shift of the cumula¬
tive risk curve to the left by as much as
8 years. A review of the Figure, based
on this left shift, would not alter our
observations regarding the similarity
in risk between the AD and PCG rela¬
tives, but would have the effect of low¬
ering the age at which risk approaches
50%.
We were cautious in our interpreta¬
tion of the maximum estimates of cu¬
mulative risk from our data. Maxi¬
mum estimates from cumulative inci¬
dence curves produce large standard
errors as is indicated in our figure,
particularly for the very old ages
where the number of survivors dimin¬
ish. Thus, beyond the age of 90 years,
maximum estimates may not be as ac¬
curate.
We have found that issues of valid¬
ity and specificity have considerable
impact on the interpretation of cumu¬
lative risk and the calculation of odds
ratios in the first-degree relatives of
these patients. While our data do not
lessen the likelihood that heredity
plays a role in the cause of AD, they do
imply that other forms of dementia
and other cognitive disorders can pro¬
duce similar risks in first-degree fam¬
ily members. Therefore, other risk fac¬
tors must be investigated in the cause
of AD.
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